Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Hanley

Showing results (241-250 of 267) with videos related to

Pageof 27
Sort By:
Medrxiv : the Preprint Server for Health Sciences|January 19, 2022
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysisLeon Di Stefano, Elizabeth L Ogburn, Malathi Ram, et al.
Plos One|September 29, 2022
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysisLeon Di Stefano, Elizabeth L Ogburn, Malathi Ram, et al.
JAMA Network Open|October 5, 2023
Leveraging the Expertise of the CTSA Program to Increase the Impact and Efficiency of Clinical TrialsPaul A Harris, Sarah E Dunsmore, Jane C Atkinson, et al.
Stroke|December 22, 2023
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Science Immunology|April 23, 2021
Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhageMichael H Askenase, Brittany A Goods, Hannah E Beatty, et al.
The Lancet. Neurology|October 19, 2016
Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trialDaniel F Hanley, Richard E Thompson, John Muschelli, et al.
Transfusion|March 30, 2022
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?Evan M Bloch, Aaron A R Tobian, Shmuel Shoham, et al.
American Journal of Hematology|July 2, 2024
Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot studyJames F Casella, Dana K Furstenau, Robert J Adams, et al.
Contemporary Clinical Trials|December 28, 2022
Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experienceAngelique E Boutzoukas, Rachel Olson, Mary Ann Sellers, et al.
Pageof 27

Showing results (241-250 of 267) with videos related to

Sort By:
Pageof 27
Medrxiv : the Preprint Server for Health Sciences|January 19, 2022
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysisLeon Di Stefano, Elizabeth L Ogburn, Malathi Ram, et al.
Plos One|September 29, 2022
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysisLeon Di Stefano, Elizabeth L Ogburn, Malathi Ram, et al.
JAMA Network Open|October 5, 2023
Leveraging the Expertise of the CTSA Program to Increase the Impact and Efficiency of Clinical TrialsPaul A Harris, Sarah E Dunsmore, Jane C Atkinson, et al.
Stroke|December 22, 2023
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Science Immunology|April 23, 2021
Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhageMichael H Askenase, Brittany A Goods, Hannah E Beatty, et al.
The Lancet. Neurology|October 19, 2016
Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trialDaniel F Hanley, Richard E Thompson, John Muschelli, et al.
Transfusion|March 30, 2022
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?Evan M Bloch, Aaron A R Tobian, Shmuel Shoham, et al.
American Journal of Hematology|July 2, 2024
Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot studyJames F Casella, Dana K Furstenau, Robert J Adams, et al.
Contemporary Clinical Trials|December 28, 2022
Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experienceAngelique E Boutzoukas, Rachel Olson, Mary Ann Sellers, et al.
Pageof 27